Screener
Ligand Pharmaceuticals LGND Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $55.96M-59.9% | $1.01B+1,388% | $115.09M+140% | $174.93M+142% | $139.38M+119% | ||
| $391.44M-25.5% | $351.06M+97.9% | $664.33M+313% | $558.59M+204% | $525.15M+237% | ||
| $83.22M+44.6% | $67.01M+62.3% | $53.38M+38.7% | $59.6M+55.3% | $57.56M+67.7% | ||
| $14.51M+21.9% | $10.26M-33.7% | $13.27M-9.2% | $9.13M-35.3% | $11.9M-28.9% | ||
| $608.23M-19.3% | $1.46B+313% | $865.42M+180% | $832.27M+151% | $753.92M+144% | ||
| —— | $3.4M-6.5% | $3.44M-4.9% | $3.57M-76.4% | $3.47M-77.0% | ||
| $207.86M+105% | $101.54M0.0% | $101.54M0.0% | $101.54M-3.5% | $101.54M-3.5% | ||
| $302.04M+29.3% | $209.24M-16.3% | $217.34M-15.9% | $225.44M-15.5% | $233.54M-15.0% | ||
| $2.24B+51.5% | $2.19B+130% | $1.53B+69.2% | $1.56B+65.7% | $1.48B+54.7% | ||
| $4.1M+11.3% | $9.41M+9.6% | $5.26M-1.9% | $3.24M-38.1% | $3.68M-21.6% | ||
| —— | $621K+459% | $621K+515% | $621K0.0% | $621K-46.1% | ||
| $500.57M+1,539% | $46.74M-27.8% | $40.67M-30.7% | $37.45M+0.9% | $30.54M+23.3% | ||
| —— | $1.13B— | —— | —— | —— | ||
| $1.28B+142% | $3.42M-97.2% | $3.94M-96.4% | $3.22M-97.1% | $526.6M+363% | ||
| 20K-100.0% | 60M0.0% | 60M0.0% | 60M+299,900% | 60M0.0% | ||
| $554.77M-4.1% | $583.25M+26.4% | $594.74M+30.3% | $608.09M+21.9% | $578.22M+9.1% | ||
| $961.76M+1.2% | $967.52M+16.9% | $997.32M+25.4% | $1.02B+22.5% | $950.17M+13.0% | ||
| $2.24B+51.5% | $2.19B+130% | $1.53B+69.2% | $1.56B+65.7% | $1.48B+54.7% |
FAQ
- What are Ligand Pharmaceuticals's total assets?
- Ligand Pharmaceuticals (LGND) holds $2.2B in total assets, up 51.5% year over year.
- How much debt does Ligand Pharmaceuticals have?
- Ligand Pharmaceuticals carries $474.3M in total debt against $961.8M of shareholders' equity, a debt-to-equity ratio of 0.49.
- How much cash does Ligand Pharmaceuticals have?
- Ligand Pharmaceuticals holds $56.0M in cash and equivalents.
- Can Ligand Pharmaceuticals cover its short-term obligations?
- Its current ratio is 1.22 — current assets exceed current liabilities.
- Where does Ligand Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Ligand Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
